Keywords: recordati, net, income, rockets, having, already, reported
Recordati's 2000 net income rockets
Article | 02 March 2001
Having already reported a 30.9% rise in consolidated net sales for 2000to 689 billion lire ($337.5 million; Marketletter January 19), Recordati of Italy says ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
